Hepatitis B virus (HBV) genotype determination by the COBAS® AmpliPrep/COBAS® TaqMan® HBV Test, v2.0 in serum and plasma matrices

Journal of Clinical Virology

Volumn 45, Issue 3, 2009, Pages 232-236

  Goedel, Sebastian ^a   Rullkoetter, Matthias ^a   Weisshaar, Sabrina ^a   Mietag, Carola ^a   Leying, Hermann ^a   Boehl, Florian ^a  

^a Roche Diagnostics Ltd   (Switzerland)

Author keywords

AmpliPrep; COBAS; Fully automated; HBV genotypes; Quantification; TaqMan

Indexed keywords

EDETIC ACID;

AMPLIPREP/COBAS; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; COBAS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; STANDARD; TAQMAN; VIRUS CONCENTRATION; VIRUS DETECTION; VIRUS LOAD; VIRUS MUTANT; WORLD HEALTH ORGANIZATION;

GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PLASMA; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SERUM; VIRAL LOAD;

EID: 67649202159     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.05.021     Document Type: Article

References (25)

1. Lee W.M. Hepatitis B virus infection. N Engl J Med 337 (1997) 1733-1745
2. Lai C.L., and Yuen M.F. The natural history of chronic hepatitis B. J Viral Hepatitis 14 Suppl. 1 (2007) 6-10
3. Weisberg I.S., Brown Jr. R.S., and Sigal S.H. Hepatitis B and end-stage liver disease. Clin Liver Dis 11 (2007) 893-916 ix
4. World Health Organization (WHO) fact sheet N°204. Hepatitis B; 2008. www.who.int/mediacentre/factsheets/fs204/en/.
5. Echevarría J.M., and Avellón A. Hepatitis B virus genetic diversity. J Med Virol 78 Suppl. 1 (2006) S36-42
6. Schäfer S. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13 (2007) 14-21
7. Mahtab M.A., Rahman S., Khan M., and Karim F. Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreatol Dis Int 7 (2008) 457-464
8. Palumbo E. Hepatitis B genotypes and response to antiviral therapy: a review. Am J Ther 14 (2007) 306-309
9. Liu C.J., and Kao J.H. Genetic variability of hepatitis B virus and response to antiviral therapy. Antivir Ther 13 (2008) 613-624
10. Yim H.J., and Lok A.S. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43 (2006) S173-S181
11. Gish R.G., Perrillo R.P., and Jacobson I.M. Customizing the management of chronic hepatitis B virus infection. Semin Liver Dis 27 Suppl. 1 (2007) 9-17
12. Buti M., and Esteban R. Drugs in development for hepatitis B. Drugs 65 (2005) 1451-1460
13. Hadziyannis S.J. New developments in the treatment of chronic hepatitis B. Expert Opin Biol Ther 6 (2006) 913-921
14. Xu X.W., and Chen Y.G. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreatol Dis Int 5 (2006) 350-359
15. Bowden S. Serological and molecular diagnosis. Semin Liver Dis 26 (2006) 97-103
16. Kessler H.H., Preininger S., Stelzl E., Daghofer E., Santner B.I., Marth E., et al. Identification of different states of hepatitis B virus infection with a quantitative PCR assay. Clin Diagn Lab Immunol 7 (2000) 298-300
17. Jardi R., But M., Rodriguez-Frias F., Cortina M., Esteban R., Guardia J., et al. The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol 24 (1996) 680-685
18. Mason A.L., Xu L., Guo L., Kuhns M., and Perrillo R.P. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 27 (1998) 1736-1742
19. Nagata I., Colucci G., Gregorio G.V., Cheeseman P., Williams R., Mieli-Vergani G., et al. The role of HBV DNA quantitative PCR in monitoring the response to interferon treatment in chronic hepatitis B virus infection. J Hepatol 30 (1999) 965-969
20. Saito T., Shinzawa H., Uchida T., Kawamata O., Honma S., Watanabe H., et al. Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B. J Med Virol 58 (1999) 325-331
21. Puchhammer-Stockl E., Mandl C.W., Kletzmayr J., Holzmann H., Hofmann A., Aberle S.W., et al. Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplant patients during lamivudine therapy. J Infect Dis 181 (2000) 2063-2066
22. Hochberger S., Althof D., Gallegos de Schrott R., Nachbaur N., Röck H., and Leying H. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol 35 (2006) 373-380
23. Allice T., Cerutti F., Pittaluga F., Varetto S., Gabella S., Marzano A., et al. COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma. J Clin Microbiol 45 (2007) 828-834
24. Saldanha J., Gerlich W., Lelie N., Dawson P., Heermann K., Heath A., et al. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 80 (2001) 63-71
25. Weiss J., Wu H., Farrenkopf B., Schultz T., Song G., Shah S., et al. Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard. J Clin Virol 30 (2004) 86-93